99.0% PURITY LOT VL-2800-A Ipamorelin
A selective pentapeptide growth-hormone secretagogue supplied as a 5 mg lyophilized vial for research into growth hormone release, ghrelin receptor signaling, and metabolic activity.
A selective pentapeptide growth-hormone secretagogue supplied as a 10 mg lyophilized vial for research into growth hormone release, ghrelin receptor signaling, and metabolic activity.
- 1 × Ipamorelin 5mg vial
- Tamper-evident flip-off cap
- Batch-tested for purity (≥99%)
- Lyophilized for stability during shipping
- Bacteriostatic water (3 mL)
- 1 × Ipamorelin 10mg vial
- Tamper-evident flip-off cap
- Batch-tested for purity (≥99%)
- Lyophilized for stability during shipping
- Bacteriostatic water (3 mL)
About this compound
A selective pentapeptide growth-hormone secretagogue supplied as a 5 mg lyophilized vial for research into growth hormone release, ghrelin receptor signaling, and metabolic activity.
- 5 mg lyophilized peptide per vial
- Selective ghrelin/GH-secretagogue receptor agonist
- Synthetic pentapeptide, ≥99% purity
- Studied for selective growth hormone release
A selective pentapeptide growth-hormone secretagogue supplied as a 10 mg lyophilized vial for research into growth hormone release, ghrelin receptor signaling, and metabolic activity.
- 10 mg lyophilized peptide per vial
- Selective ghrelin/GH-secretagogue receptor agonist
- Synthetic pentapeptide, ≥99% purity
- Studied for selective growth hormone release
Why the lot matters
- Synthesized and tested per lot, never as a production-run average
- Certificate of Analysis published before the lot goes on sale
- Independent lab, contractually separate from manufacturing
What "research use only" means
This product is sold exclusively for in-vitro laboratory research. It is not evaluated by any medicines agency and is not intended for human or animal administration, diagnosis, treatment, or prevention of disease.
Technical data
Technical data
Current lot snapshot
Shipping
Reported use in research
Ipamorelin is a selective synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts as an agonist at the ghrelin/growth-hormone-secretagogue receptor. It is investigated as a growth-hormone-releasing peptide in preclinical and animal research models. Research indicates that it stimulates the secretion of growth hormone through a pathway distinct from growth-hormone-releasing hormone. It is studied for its reported selectivity, prompting growth hormone release while showing minimal effect on cortisol and prolactin in research models. These characteristics have made it a subject of interest in endocrinology and secretagogue research.
Reported findings
Research reports that Ipamorelin induces a dose-dependent release of growth hormone in animal research models, with a profile described as more selective than earlier secretagogues. In these models it has been reported to elevate growth hormone with minimal accompanying increases in cortisol, prolactin, or adrenocorticotropic hormone. Investigators have examined its potential influence on markers associated with lean mass, bone turnover, and metabolism in preclinical settings. These properties have positioned it as a subject of ongoing interest in growth hormone and ghrelin receptor research models.
Handling & safety
The full safety and toxicological profile of Ipamorelin has not been completely characterized in research models. It is intended solely for in vitro and laboratory research and should be handled by qualified personnel using appropriate personal protective equipment. As with all research peptides, contact with skin, eyes, and mucous membranes should be avoided, and any exposure or ingestion prevented. Reported findings are limited to controlled experimental settings and should not be interpreted as indicating safety in any other context.
Reconstitution
Recommended ratio
- 1 mL of bacteriostatic water per 10 mg vial
- Equivalent to 10 mg/mL (i.e. 1 mg per 10 units on a 100 U insulin syringe)
- Remove the plastic flip-off lid from the vial.
- Disinfect the rubber stoppers with alcohol wipes.
- Inject the diluent slowly down the inner wall of the vial to avoid foaming.
- Gently swirl the vial (never shake). Let it dissolve for about 10 minutes.
Storage
Unopened / before reconstitution
- Store at a stable temperature.
- Stable for 24 months.
- For long-term storage (2+ years), store at -20 °C.
Reconstituted solution
- Must be kept refrigerated.
- Avoid exposure to light and excessive heat.
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 711.9 g/mol | PASS |
| Purity | HPLC (area %) | 99.0% | PASS |
| Net peptide content | Gravimetric | 5.01 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 711.9 g/mol | PASS |
| Purity | HPLC (area %) | 99.1% | PASS |
| Net peptide content | Gravimetric | 5.00 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 711.9 g/mol | PASS |
| Purity | HPLC (area %) | 99.2% | PASS |
| Net peptide content | Gravimetric | 10.01 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 711.9 g/mol | PASS |
| Purity | HPLC (area %) | 99.3% | PASS |
| Net peptide content | Gravimetric | 10.02 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 711.9 g/mol | PASS |
| Purity | HPLC (area %) | 99.0% | PASS |
| Net peptide content | Gravimetric | 10.02 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
| Lot | Filled | Purity | Report | Status | |
|---|---|---|---|---|---|
| VL-2800-A | Jul 2026 | 99.0% | TR-88558 | Active | |
| VL-2819-B | May 2026 | 99.1% | TR-88491 | Sold out |
| Lot | Filled | Purity | Report | Status | |
|---|---|---|---|---|---|
| VL-2958-A | Jul 2026 | 99.2% | TR-88396 | Active | |
| VL-2977-B | May 2026 | 99.3% | TR-88481 | Sold out | |
| VL-2920-C | Mar 2026 | 99.0% | TR-88486 | Sold out |
